Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Zimmer Biomet (NYSE:ZBH) announced that its management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8.
Rhea-AI Summary
Zimmer Biomet (NYSE:ZBH) announced that its management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8. A fireside chat is scheduled for 10:40 a.m. ET, with a live audio webcast and replay available on the company’s investor relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – ZBH
On Jun 2, the day this news came out, ZBH closed 0.98% above the previous close.
Data tracked by StockTitan Argus for the Jun 2 session.
Key Figures
- Conference date
- June 8, 2026
- Goldman Sachs 47th Annual Global Healthcare Conference
- Fireside chat time
- 10:40 a.m. ET
- Scheduled Zimmer Biomet management session
Historical Context
-
Board approved a $0.24 Q2 2026 cash dividend.
-
Raised 2026 share repurchase expectations to up to $1 billion.
-
Announced BofA conference fireside chat with webcast access.
-
Reported higher Q1 sales, earnings, cash flow, and raised 2026 guidance.
-
Announced CFO departure and appointment of an interim CFO.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., June 2, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8 with a fireside chat at 10:40 a.m. ET.
A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the fireside chat.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.
Contacts:
Media Troy Kirkpatrick 614-284-1926 troy.kirkpatrick@zimmerbiomet.com
Kirsten Fallon 781-779-5561 | Investors David DeMartino 646-531-6115 david.demartino@zimmerbiomet.com
Zach Weiner 908-591-6955 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302787549.html
SOURCE Zimmer Biomet Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.